Efficient Evaluation of In Vivo Performance in Human for Generic Formulation by Novel Dissolution-Absorption Prediction (DAP) Workflow.
Motoki OnishiKozo TagawaMaiko JikoKayo KoikeMasato MaruyamaHidetoshi HashizumeKazuhide ImagakiKazutaka HigakiPublished in: Pharmaceutical research (2022)
The DAP workflow would be valuable for estimating the in vivo performance of generic formulation and deducing their bioequivalence with the original formulation.